With MDx Usage and Costs on the Rise, UnitedHealthCare Urges Reimbursement Reform
March 14, 2012
With MDx Usage and Costs on the Rise, UnitedHealthCare Urges Reimbursement Reform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Personalized Medicine in 2011: Some Successes, Slow Progress, Continued Economic Woes
January 4, 2012 / Pharmacogenomics Reporter - Palmetto's Loss of Jurisdiction E Medicare Contract Raises Questions About Fate of MolDx Program
October 17, 2012 / Pharmacogenomics Reporter - CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter - Avalere Predicts Genomic Medicine Interventions will be Subject of CMS National Coverage Decisions
January 25, 2012 / Pharmacogenomics Reporter - AMA Threatens to File HIPAA Complaint Unless CMS Halts Program Requiring Z-Codes for MDx Tests
January 4, 2012 / Pharmacogenomics Reporter